Ivan Topchiysky assumed the position of Chairman of the Board of Directors at Bulgargaz EAD in early 2022. His professional journey began in the audit department of KPMG Bulgaria, where he advanced from Junior Auditor to Audit Manager over four years. Subsequently, he served as Chief Financial Officer and Board Member at digital media group Net Info. In 2012, Ivan Topchiysky joined the headquarters of pharmaceutical company Merck in Darmstadt, Germany, and later became CFO of Merck Eastern Europe, along with serving as CEO and Chairman of the Board of Merck Group companies in Bulgaria, Croatia, and Slovenia. From 2016 to 2020, he was engaged in private healthcare ventures and served as CFO of the generic division Sandoz at Novartis.
Originally from Sofia, Ivan Topchiysky graduated from the National High School in Finance and Business (NHSFB) in Sofia. He holds a Bachelor's degree in Business Administration and Accounting from California Baptist University, a Master's Degree in Health Management from the Medical University of Sofia (2008), and a Master's Degree in Business Administration from the Mannheim Business School in Germany (2012). Additionally, he is ACCA certified and a member of the Association of Chartered Certified Accountants of Great Britain.
Ivan Topchiysky is fluent in English.